Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Solmi

Showing results (71-80 of 580) with videos related to

Pageof 58
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 26, 2024
Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysisNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
BMJ Mental Health|December 18, 2024
<b>Umbrella-Review, Evaluation, Analysis and Communication Hub (U-REACH</b>): <b>a novel living umbrella review knowledge translation approach</b>Corentin J Gosling, Samuele Cortese, Joaquim Radua, et al.
Laboratory Animals|September 20, 2023
Twelve years after the ARRIVE guidelines: Animal research has not yet arrived at high standardsJunmin Song, Marco Solmi, Andre F Carvalho, et al.
Brain and Behavior|December 26, 2019
Test-retest reliability of the Italian version of the M-BACK questionnaire to assess the barriers, attitudes, confidence, and knowledge of mental health staff regarding metabolic health of psychiatric patientsAttilio Carraro, Erica Gobbi, Marco Solmi, et al.
Schizophrenia Bulletin|July 21, 2021
Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design StudyMarco Solmi, Jari Tiihonen, Markku Lähteenvuo, et al.
JCPP Advances|July 11, 2023
Increasing referrals to emergency department for psychiatric consultation and treatment among 50,056 adolescents and young adults: Predictors and implicationsMarco Solmi, Foscarina Della Rocca, Umberto Granziol, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2025
On the potential of xanomeline-trospium chloride for schizophrenia and beyondNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
Health Science Reports|September 29, 2025
Relative Risk of All-Cause Mortality Associated With Cannabis Use: A Systematic Review and Meta-Analysis of Cohort StudiesZainab Alimoradi, Chung-Ying Lin, Daniel T Myran, et al.
Epidemiology and Psychiatric Sciences|January 31, 2019
Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritisMarco Solmi, Ai Koyanagi, Trevor Thompson, et al.
Neuroscience and Biobehavioral Reviews|September 13, 2025
Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic reviewDimitri Fiani, Sana Chahine, Mira Zaboube, et al.
Pageof 58

Showing results (71-80 of 580) with videos related to

Sort By:
Pageof 58
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 26, 2024
Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysisNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
BMJ Mental Health|December 18, 2024
<b>Umbrella-Review, Evaluation, Analysis and Communication Hub (U-REACH</b>): <b>a novel living umbrella review knowledge translation approach</b>Corentin J Gosling, Samuele Cortese, Joaquim Radua, et al.
Laboratory Animals|September 20, 2023
Twelve years after the ARRIVE guidelines: Animal research has not yet arrived at high standardsJunmin Song, Marco Solmi, Andre F Carvalho, et al.
Brain and Behavior|December 26, 2019
Test-retest reliability of the Italian version of the M-BACK questionnaire to assess the barriers, attitudes, confidence, and knowledge of mental health staff regarding metabolic health of psychiatric patientsAttilio Carraro, Erica Gobbi, Marco Solmi, et al.
Schizophrenia Bulletin|July 21, 2021
Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design StudyMarco Solmi, Jari Tiihonen, Markku Lähteenvuo, et al.
JCPP Advances|July 11, 2023
Increasing referrals to emergency department for psychiatric consultation and treatment among 50,056 adolescents and young adults: Predictors and implicationsMarco Solmi, Foscarina Della Rocca, Umberto Granziol, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2025
On the potential of xanomeline-trospium chloride for schizophrenia and beyondNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
Health Science Reports|September 29, 2025
Relative Risk of All-Cause Mortality Associated With Cannabis Use: A Systematic Review and Meta-Analysis of Cohort StudiesZainab Alimoradi, Chung-Ying Lin, Daniel T Myran, et al.
Epidemiology and Psychiatric Sciences|January 31, 2019
Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritisMarco Solmi, Ai Koyanagi, Trevor Thompson, et al.
Neuroscience and Biobehavioral Reviews|September 13, 2025
Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic reviewDimitri Fiani, Sana Chahine, Mira Zaboube, et al.
Pageof 58